Pharmaceuticals: Other
Japanese companies producing specialized pharmaceuticals
Firms in this secondary pharmaceutical group focus on niche therapeutics, animal health products, or specialized clinical compounds. Specific patent rulings and localized regulatory approvals inject sudden volatility into these stocks. Right now, euglena Co., Ltd. tops trading volume. You can find more fundamental and technical metrics in the table below.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.78 B JPY | 303 JPY | −6.77% | 1.44 M | 1.64 | — | −1.29 JPY | +81.31% | 0.62% | Health technology | No rating | |
| 21.95 B JPY | 538 JPY | −2.89% | 295.9 K | 0.89 | 8.50 | 63.33 JPY | — | 3.31% | Health technology | No rating | |
| 17.12 B JPY | 556 JPY | −5.76% | 333.6 K | 1.67 | 8.17 | 68.05 JPY | +406.78% | 4.23% | Health technology | No rating | |
| 13.5 B JPY | 970 JPY | −0.82% | 14.3 K | 2.03 | 17.67 | 54.91 JPY | −73.55% | 3.06% | Health technology | No rating | |
| 8.92 B JPY | 2,164 JPY | −1.73% | 5.9 K | 2.73 | 11.24 | 192.50 JPY | +69.36% | 2.97% | Health technology | No rating | |
| 8.74 B JPY | 872 JPY | −6.94% | 15 K | 1.87 | 9.43 | 92.52 JPY | −22.06% | 2.38% | Health technology | No rating | |
| 7.18 B JPY | 160 JPY | −6.98% | 563.5 K | 2.52 | — | −28.97 JPY | +3.12% | 0.00% | Health technology | No rating | |
| 7.1 B JPY | 68 JPY | −8.11% | 1.43 M | 2.40 | — | −13.45 JPY | −7.78% | 0.00% | Health technology | No rating |